Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients-Reference-Cited by-同舟云学术

Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients

Published:2016-01-08 Issue:3 Volume:10 Page:290-299
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Oonk Stijn¹,Spitali Pietro¹,Hiller Monika¹,Switzar Linda¹²,Dalebout Hans²,Calissano Mattia³,Lochmüller Hanns³,Aartsma-Rus Annemieke¹³,Hoen Peter A. C.’t¹,van der Burgt Yuri E. M.²

Affiliation:

1. Department of Human Genetics; Leiden University Medical Center (LUMC); Leiden The Netherlands

2. Center for Proteomics and Metabolomics; Leiden University Medical Center (LUMC); Leiden The Netherlands

3. John Walton Muscular Dystrophy Research Center; International Centre for Life, Central Parkway; Newcastle University; Newcastle upon Tyne United Kingdom

Funder

European Union Seventh Framework Programme

Biomarkers for neuromuscular disorders

NEUROMICS

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201500044/fullpdf

Reference55 articles.

1. Interventions for muscular dystrophy: molecular medicines entering the clinic;Bushby;Lancet,2009